Provider Reviews

Start Willow vs JoinSkinny: Pricing, Shipping, and Medication Differences

Start Willow vs JoinSkinny: both are telehealth weight-loss services that avoid insurance, but Start Willow focuses on compounded semaglutide with a fast 3-day delivery guarantee while JoinSkinny emphasizes flat-rate plans, bundles, and next-day temperature-controlled shipping. Early verdict: choose Start Willow if you want a compounded semaglutide option with guaranteed 3-day delivery and a direct-pay model; choose JoinSkinny if you want lower starting plans, flat-rate dosing, and multi-month bundles.

Explore Start Willow prices and semaglutide details

Head-to-head at a glance: pricing, shipping, and product type

Criteria Start Willow JoinSkinny
Starting price From $249 per Month; $249 first month, $299/month ongoing Plans starting at $149; promotional $140 off available
Medication type Compounded semaglutide comparable to Ozempic and tirzepatide GLP-1 and GLP-1+GIP options; authentic injections filled by licensed U.S. pharmacies
Shipping speed and handling Delivery guaranteed in 3 days or less; same day prescriptions and free 2-Day shipping noted Free temperature-controlled shipping; arrives in 1-2 days; same-day ship if before 2 pm CT
Pricing model Direct-pay, no insurance, no membership fees; price rises to $299 ongoing Transparent flat-rate monthly pricing; monthly and 3-, 6-, 12-month bundles and installment options
Regulatory note Compounded semaglutide is not FDA-approved; not reviewed by FDA Compounded products are not FDA-approved; branded prescriptions filled separately by licensed, FDA-regulated pharmacies

1. Price and payment structure compared

Start Willow begins at $249 per month with ongoing pricing at $299/month according to captured evidence. JoinSkinny advertises plans starting at $149, with a promotional $140 discount and options for multi-month bundles. Start Willow uses a direct-pay, no-insurance model that removes prior-authorization steps; JoinSkinny uses flat-rate dosing and offers bundle pricing and installment options. If long-term affordability is the priority, the sources note JoinSkinny’s lower starting prices and bundle options versus Start Willow’s higher ongoing rate.

See JoinSkinny plan options and bundle pricing

2. Medication type and regulatory status

Both providers involve medications that may not be branded finished products. Start Willow specifically offers a compounded semaglutide injection described as comparable to Ozempic and tirzepatide and notes that compounded semaglutide is not FDA-approved and not reviewed by the FDA. JoinSkinny provides GLP-1 and GLP-1+GIP options and states its prescriptions are filled by U.S.-based, FDA-regulated and LegitScript-certified pharmacy partners; captured evidence also notes compounded products are not FDA-approved. These regulatory qualifiers are preserved in both providers’ materials.

Review Start Willow compounded semaglutide information

3. Delivery speed and logistics

Start Willow guarantees delivery in 3 days or less and highlights same-day prescriptions and free 2-Day shipping in landing-page evidence. JoinSkinny promises temperature-controlled shipping that arrives in 1-2 days, with same-day shipping for prescriptions received before 2 pm central time and UPS next-day delivery. Both emphasize fast shipping, but JoinSkinny highlights temperature control and specific cutoffs for same-day ship dates.

4. Clinical flow and support

Start Willow prescribes compounded semaglutide after an online clinician review and positions its model as fully online with no in-person visits or insurance forms. JoinSkinny uses a quick health questionnaire followed by a licensed provider review, includes prescription and telemed visits in its plans, and offers ongoing support, dose adjustments, monthly check-ins, and 24/7 chat. The evidence shows JoinSkinny emphasizes continuous monitoring and dose adjustments at no extra cost, while Willow emphasizes a personalized clinician-prescribed compounded option.

What matters most: three decisive differences

1) Price and bundles: JoinSkinny starts lower and offers multi-month bundles and installment options; Start Willow has a higher ongoing rate after the first month. 2) Medication framing: Start Willow centers on a compounded semaglutide product comparable to branded GLP-1s; JoinSkinny offers GLP-1 and GLP-1+GIP options with prescriptions filled by FDA-regulated pharmacies. 3) Shipping specifics: Start Willow guarantees delivery in 3 days or less; JoinSkinny emphasizes temperature-controlled 1–2 day shipping with same-day ship cutoffs.

Near-conclusion summary

Start Willow vs JoinSkinny comes down to tradeoffs between a compounded semaglutide direct-pay option with a 3-day delivery guarantee and a lower-cost, flat-rate plan structure with bundle options and temperature-controlled next-day shipping. Both avoid insurance and both include clinician review, but the regulatory qualifier that compounded medications are not FDA-approved appears in both providers’ captured evidence.

Choose Start Willow if…

You prioritize a compounded semaglutide option prescribed as part of a personalized treatment plan, want a direct-pay model that bypasses insurance prior authorizations, and value Start Willow’s 3-day delivery guarantee.

Choose JoinSkinny if…

You want lower starting plans, flat-rate dosing with consistent monthly price regardless of dose increases, multi-month bundles or installment options, and temperature-controlled 1–2 day shipping with same-day ship cutoffs.

Compare JoinSkinny eligibility and shipping details

Start Willow: check pricing and clinician review process

Primary keyword: Start Willow vs JoinSkinny

Ready to Compare Telehealth Providers?

Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.

Compare All Providers →

Related articles

Medical disclaimer: This page is for informational purposes only and is not medical advice. Always consult a licensed healthcare provider before starting any treatment. We may earn a commission from partner links on this page - see our advertising disclosure.